Chronic Renin–Angiotensin System (RAS) Blockade May Not Induce Hypotension During Anaesthesia for Bariatric Surgery

Obesity Surgery

Volumn 26, Issue 6, 2016, Pages 1303-1307

  Salvetti, Guido ^a   Di Salvo, Claudio ^a   Ceccarini, Giovanni ^a   Abramo, Antonio ^a   Fierabracci, Paola ^a   Magno, Silvia ^a   Piaggi, Paolo ^a   Vitti, Paolo ^a   Santini, Ferruccio ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

ACE inhibitors; Anaesthesia; Bariatric surgery; Hypertension; Sartans

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CISATRACURIUM; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; HYDROCHLOROTHIAZIDE; PROPOFOL; SEVOFLURANE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; LOW DRUG DOSE; MALE; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PILOT STUDY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; HYPERTENSION; MORBID OBESITY; PROCEDURES;

ADULT; ANESTHESIA, GENERAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BARIATRIC SURGERY; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; OBESITY, MORBID; PERIOPERATIVE CARE; PILOT PROJECTS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84940504612     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1862-9     Document Type: Article

References (22)

1. Ramírez-Sánchez M, Prieto I, Wangensteen R, et al. The renin-angiotensin system: new insight into old therapies. Curr Med Chem. 2013;20:1313–22.
2. Kataja JH, Kaukinen S, Viinamäki OV, et al. Hemodynamic and hormonal changes in patients pretreated with captopril for surgery of the abdominal aorta. J Cardiothorac Vasc Anesth. 1989;3:425–32.
3. Augoustides JG. Angiotensin blockade and general anesthesia: so little known, so far to go. J Cardiothorac Vasc Anesth. 2008;22(2):177–9.
4. Brabant SM, Bertrand M, Eyraud D, et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89:1388–92.
5. Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg. 1999;89:1143–55.
6. Cozanitis DA. The importance of interrupting angiotensin converting enzyme inhibitor treatment before spinal anaesthesia—a controlled case report. Anaesthesiol Reanim. 2004;29(1):16–8.
7. Meersschaert K, Brun L, Gourdin M, et al. Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective randomized, double-blinded, crossover study. Anesth Analg. 2002;94:835–40.
8. Boccara G, Ouattara A, Godet G, et al. Terlipressin versus norepinephrine to correct arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors. Anesth Analg. 2003;98:1338–44.
9. Bertrand M, Godet G, Meersschaert K, et al. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001;92:26–30.
10. Comfere T, Sprung J, Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100:636–44.
11. Kheterpal S, Khodaparast O, Shanks A, et al. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth. 2008;22(2):180–6.
12. Jordan J, Yumuk V, Schlaich M, et al. Joint statement of the European Association for the study of obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens. 2012;30(6):1047–55.
13. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3–60 month follow-up. Obes Surg. 2000;10(3):233–9.
14. Chowbey PK, Dhawan K, Khullar R, et al. Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results. Obes Surg. 2010;20(10):1340–7.
15. Romagnoli S, Ricci Z, Quattrone D, et al. Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational study. Crit Care. 2014;18(6):644.
16. Araghi A, Bander JJ, Guzman JA. Arterial blood pressure monitoring in overweight critically ill patients: invasive or noninvasive? Crit Care. 2006;10(2):R64.
17. Behnia R, Molteni A, Igic R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des. 2003;9:763–76.
18. 2+ channel blocker. Anesth Analg. 1993;76:24–32.
19. Maguire AM, Kumar N, Parker JL, et al. Comparison of effects of remifentanil and alfentanil on cardiovascular response to tracheal intubation in hypertensive patients. Br J Anaesth. 2001;86:90–3.
20. Twersky RS, Goel V, Narayan P, et al. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients. Anesth Analg. 2014;118(5):938–44.
21. Auron M, Harte B, Kumar A, et al. Renine angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice. Postgrad Med J. 2011;87(1029):472–81.
22. Rosei EA, Salvetti M, Farsang C. European society of hypertension scientific newsletter: treatment of hypertensive urgencies and emergencies. J Hypertens. 2006;24(12):2482–5.